Keywords

• Atazanavir powder
• Atazanavir price
• Atazanavir manufacture

Quick Details

• ProName: Atazanavir 198904-31-3 manufacturer/su...
• CasNo: 198904-31-3
• Molecular Formula: C8H17NO2
• Appearance: powder
• Application: Chemical raw materials
• DeliveryTime: 1-3days
• PackAge: drums /Al foil bag
• Port: Shenzhen
• ProductionCapacity: 1000 Metric Ton/Month
• Purity: 99%
• Storage: cool dry place
• Transportation: By express/air/sea
• LimitNum: 50 Gram
• Valid Period: 2years
• color: white

Superiority

Our advantage :

1.We have 2 ISO certificated Manufactures ,costs control  better ,Production quality is more guaranteed;

2.Strictly  lab test  for quality control ;

3.Professional sales team and after-sales service;

4.Safe delivery method .

Product Advantage :

1. Pharmacological efficacy: Pregabalin is a novel γ-aminobutyric acid (GABA) receptor agonist, can block the voltage-dependent calcium channels to reduce neurotransmitter release.

2. The main clinical for the treatment of peripheral neuropathic pain as well as part of adjuvant treatment of focal seizures.
3. Treatment of epilepsy in developing the most promising drug in a drug treatment better and more convenient administration. Can also be used to treat pain and anxiety.

Details

Atazanavir is an oral medication that is used for treating infections caused by the human immunodeficiency virus(HIV). It is in a class of drugs called protease inhibitors that also includesritonavir , nelfinavir (Viracept), indinavir (Crixivan) and saquinavir(Invirase, Fortovase). During infection with HIV, the HIV virus multiplies within the body's cells. Viruses are released from the cells and spread throughout the body where they infect other cells. In this manner, HIV infection is perpetuated among new cells that the body produces continually. During the production of the viruses, new proteins must be made. Some of the proteins are structural proteins, that, is, proteins that form the body of the new viruses. Other proteins are enzymes that manufacture DNA and other components for the new viruses. Protease is the enzyme that forms the new structural proteins and enzymes. Atazanavir blocks the activity of protease and results in the formation of new viruses with defective proteins that are unable to infect the body's cells. As a result, the number of viruses in the body (the viral load) decreases. Nevertheless, atazanavir does not prevent the transmission of HIV among individuals, and it does not cure HIV infections or AIDS. Atazanavir was approved by the FDA in June 2003.